BeOne Medicines
ONC
#607
Rank
$42.03 B
Marketcap
$371.61
Share price
1.74%
Change (1 day)
11.65%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): $5.98

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is $5.98. In 2025 the company made an earnings per share (EPS) of $2.73 an increase over its 2024 EPS that were of -$6.24.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$5.98119.05%
2025$2.73-143.75%
2024-$6.24
2022-$19.5028.21%
2021-$15.21-19.96%
2020-$19.0020.81%
2019-$15.7331.52%
2018-$11.96417.57%
2017-$2.31-37.16%
2016-$3.68158.95%
2015-$1.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-$0.09000-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$0.95-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA